BACKGROUND: We sought to evaluate the outcomes of transapical transcatheter mitral valve replacement in patients with degenerated mitral bioprostheses or failed mitral ring annuloplasty and high surgical risk for redo mitral valve procedure. METHODS: Between August 2012 and December 2020, 41 consecutive high-risk patients underwent transcatheter mitral 'valve-in-valve' (TM-ViV, n=25) or 'valve-in-ring' (TM-ViR, n=16) implantation at our institution. All procedures were performed in a hybrid operating theater using the SAPIEN XT/3™ or the DIRECT FLOW MEDICAL™ prostheses. Data was collected prospectively according to MVARC criteria. RESULTS: The logistic EuroSCORE-I was 42.3%±20.5% (mean ± SD), the Society of Thoracic Surgeons (STS) score was 11.9%±10.8%, and the STS/ACC-score was 7.6%±4.2%. Transcatheter mitral valve implantations were successful in all patients (100%). Early echocardiographic examinations showed no obstruction of the left ventricular outflow tract (LVOT), no paravalvular leakage, and only trace transvalvular leakage in eight patients. There was no operative mortality; thirty-day mortality was 9.8%. Survival was 72% at one year and 63% at three years. At two-year follow-up, transvalvular mean pressure gradients were 4.6±1.4 mmHg. CONCLUSIONS: Transapical transcatheter mitral valve-in-valve or valve-in-ring implantation represents a true minimally invasive alternative to surgical redo procedures, especially in high-risk patients with failed bioprosthetic mitral valves or annuloplasty and favorable anatomy. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
BACKGROUND: We sought to evaluate the outcomes of transapical transcatheter mitral valve replacement in patients with degenerated mitral bioprostheses or failed mitral ring annuloplasty and high surgical risk for redo mitral valve procedure. METHODS: Between August 2012 and December 2020, 41 consecutive high-risk patients underwent transcatheter mitral 'valve-in-valve' (TM-ViV, n=25) or 'valve-in-ring' (TM-ViR, n=16) implantation at our institution. All procedures were performed in a hybrid operating theater using the SAPIEN XT/3™ or the DIRECT FLOW MEDICAL™ prostheses. Data was collected prospectively according to MVARC criteria. RESULTS: The logistic EuroSCORE-I was 42.3%±20.5% (mean ± SD), the Society of Thoracic Surgeons (STS) score was 11.9%±10.8%, and the STS/ACC-score was 7.6%±4.2%. Transcatheter mitral valve implantations were successful in all patients (100%). Early echocardiographic examinations showed no obstruction of the left ventricular outflow tract (LVOT), no paravalvular leakage, and only trace transvalvular leakage in eight patients. There was no operative mortality; thirty-day mortality was 9.8%. Survival was 72% at one year and 63% at three years. At two-year follow-up, transvalvular mean pressure gradients were 4.6±1.4 mmHg. CONCLUSIONS: Transapical transcatheter mitral valve-in-valve or valve-in-ring implantation represents a true minimally invasive alternative to surgical redo procedures, especially in high-risk patients with failed bioprosthetic mitral valves or annuloplasty and favorable anatomy. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
Authors: Norihiko Kamioka; Vasilis Babaliaros; Michael Andrew Morse; Tiberio Frisoli; Stamatios Lerakis; Jose Miguel Iturbe; Jose Binongo; Frank Corrigan; Altayyeb Yousef; Patrick Gleason; John A Wells; Hope Caughron; Andy Dong; Evelio Rodriguez; Bradley Leshnower; William O'Neill; Gaetano Paone; Marvin Eng; Robert Guyton; Peter C Block; Adam Greenbaum Journal: JACC Cardiovasc Interv Date: 2018-06-25 Impact factor: 11.195
Authors: Sung-Han Yoon; Brian K Whisenant; Sabine Bleiziffer; Victoria Delgado; Abhijeet Dhoble; Niklas Schofer; Lena Eschenbach; Eric Bansal; Dale J Murdoch; Marco Ancona; Tobias Schmidt; Ermela Yzeiraj; Flavien Vincent; Hiroki Niikura; Won-Keun Kim; Masahiko Asami; Axel Unbehaun; Sameer Hirji; Buntaro Fujita; Miriam Silaschi; Gilbert H L Tang; Shingo Kuwata; S Chiu Wong; Antonio H Frangieh; Colin M Barker; James E Davies; Alexander Lauten; Florian Deuschl; Luis Nombela-Franco; Rajiv Rampat; Pedro Felipe Gomes Nicz; Jean-Bernard Masson; Harindra C Wijeysundera; Horst Sievert; Daniel J Blackman; Enrique Gutierrez-Ibanes; Daisuke Sugiyama; Tarun Chakravarty; David Hildick-Smith; Fabio Sandoli de Brito; Christoph Jensen; Christian Jung; Richard W Smalling; Martin Arnold; Simon Redwood; Albert Markus Kasel; Francesco Maisano; Hendrik Treede; Stephan M Ensminger; Saibal Kar; Tsuyoshi Kaneko; Thomas Pilgrim; Paul Sorajja; Eric Van Belle; Bernard D Prendergast; Vinayak Bapat; Thomas Modine; Joachim Schofer; Christian Frerker; Joerg Kempfert; Guilherme F Attizzani; Azeem Latib; Ulrich Schaefer; John G Webb; Jeroen J Bax; Raj R Makkar Journal: Eur Heart J Date: 2019-02-01 Impact factor: 29.983
Authors: Hunaid A Vohra; Robert N Whistance; Apostolos Roubelakis; Andrew Burton; Clifford W Barlow; Geoffrey M K Tsang; Steve A Livesey; Sunil K Ohri Journal: Interact Cardiovasc Thorac Surg Date: 2012-01-31
Authors: Alina Zubarevich; Konstantin Zhigalov; Marcin Szczechowicz; Matthias Thielmann; Marco Rabis; Jef Van den Eynde; Michel Pompeu B O Sá; Wilko Weissenberger; Bakytbek Kadyraliev; Soslan Enginoev; Rolf Alexander Jánosi; Alexander Lind; Tienush Rassaf; Bastian Schmack; Arjang Ruhparwar; Alexander Weymann; Daniel Wendt Journal: J Card Surg Date: 2021-01-24 Impact factor: 1.620
Authors: Manuel Wilbring; Konstantin Alexiou; Sems Malte Tugtekin; Bjoern Sill; Peter Hammer; Torsten Schmidt; Gregor Simonis; Klaus Matschke; Utz Kappert Journal: Ann Thorac Surg Date: 2012-10-11 Impact factor: 4.330
Authors: David Del Val; Alfredo Nunes Ferreira-Neto; Jerome Wintzer-Wehekind; François Dagenais; Jean-Michel Paradis; Mathieu Bernier; Kim O'Connor; Jonathan Beaudoin; Afonso B Freitas-Ferraz; Josep Rodés-Cabau Journal: J Am Heart Assoc Date: 2019-08-23 Impact factor: 5.501
Authors: Matti Adam; Elmar Kuhn; Hendrik Wienemann; Victor Mauri; Laurin Ochs; Maria Isabel Körber; Kaveh Eghbalzadeh; Christos Iliadis; Marcel Halbach; Thorsten Wahlers; Stephan Baldus Journal: Clin Res Cardiol Date: 2022-09-15 Impact factor: 6.138